- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 112,137 | 06.08.24 20:58:43 | -0,173 | -0,15% | 112,120 | 112,140 | 114,950 | 112,310 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 99,200 | 06.08.24 20:57:52 | +1,070 | +1,09% | 98,830 | 99,590 | 97,940 | 98,130 |
